pharma · HIV Infections · Major Depressive Disorder · PRAX
Praxis Precision Medicines
Praxis Precision Medicines clinical programs — 7 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Boston, USA
- Employees
- 205
- Programs
- 7
- Drugs
- 8
- Patents
- 35
Praxis Precision Medicines projects
7 ClinicalTrials.gov programs sponsored by Praxis Precision Medicines.
Praxis Precision Medicines has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Nimotuzumab
Praxis Precision Medicines
Pancreatic Cancer, Advanced or Metastatic
1 trial -
Transcutaneous Cervical Spinal Cord Stimulation
Praxis Precision Medicines
Spinal Cord Injury Cervical
1 trial -
10 mg PRAX-114
Praxis Precision Medicines
Major Depressive Disorder
1 trial -
HIV-1 C4-V3 Polyvalent Peptide Vaccine
Praxis Precision Medicines
HIV Infections
1 trial -
PRX-P4-003, (-)-FCF
Praxis Precision Medicines
Healthy Volunteers
1 trial -
Pneumococcal Vaccine, Polyvalent (23-valent)
Praxis Precision Medicines
HIV Infections
1 trial -
2021-02508
Praxis Precision Medicines
Telemedicine
1 trial
Frequently asked questions
How many clinical projects does Praxis Precision Medicines have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.